125 related articles for article (PubMed ID: 33443865)
21. Treatment and Survival of Small-bowel Adenocarcinoma in the United States: A Comparison With Colon Cancer.
Young JI; Mongoue-Tchokote S; Wieghard N; Mori M; Vaccaro GM; Sheppard BC; Tsikitis VL
Dis Colon Rectum; 2016 Apr; 59(4):306-15. PubMed ID: 26953989
[TBL] [Abstract][Full Text] [Related]
22. Tumor Budding and Poorly Differentiated Clusters in Small Intestinal Adenocarcinoma.
Jun SY; Chung JY; Yoon N; Jung ES; Oh YH; Hong SM
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32781596
[TBL] [Abstract][Full Text] [Related]
23. An Examination of Lymph Node Sampling as a Predictor of Survival in Resected Node-Negative Small Bowel Adenocarcinoma: a SEER Database Analysis.
Thiessen M; Lee-Ying RM; Monzon JG; Tang PA
J Gastrointest Cancer; 2020 Mar; 51(1):280-288. PubMed ID: 31111426
[TBL] [Abstract][Full Text] [Related]
24. Tumor Microenvironment Prognostic Risk and Its Association With MUC5AC in Ampullary Carcinoma.
Jun SY; Lee EJ; Kim SI; An S
Arch Pathol Lab Med; 2023 Sep; 147(9):1060-1074. PubMed ID: 36445719
[TBL] [Abstract][Full Text] [Related]
25. Primary malignant tumors of the small bowel.
Mittal VK; Bodzin JH
Am J Surg; 1980 Sep; 140(3):396-9. PubMed ID: 7425215
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Significance of Intratumoral and Peritumoral Budding in Distal Extrahepatic Bile Duct Carcinoma.
Jun SY; Hong SM; An S
Pathobiology; 2023 Dec; ():. PubMed ID: 38113866
[TBL] [Abstract][Full Text] [Related]
27. Adenocarcinoma of the small intestine: 21-year review of diagnosis, treatment, and prognosis.
Bauer RL; Palmer ML; Bauer AM; Nava HR; Douglass HO
Ann Surg Oncol; 1994 May; 1(3):183-8. PubMed ID: 7842287
[TBL] [Abstract][Full Text] [Related]
28. [Primary tumors of the small intestine].
Cunsolo A; Arena N; Ranieri ML; Spolaore R; Gozzetti G
Minerva Chir; 1988 Jun; 43(11):923-8. PubMed ID: 3173704
[No Abstract] [Full Text] [Related]
29. Midgut carcinoid tumours: surgical treatment and prognosis.
Kerström G; Hellman P; Hessman O
Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):717-28. PubMed ID: 16253896
[TBL] [Abstract][Full Text] [Related]
30. Loss of ARID1A expression is associated with DNA mismatch repair protein deficiency and favorable prognosis in advanced stage surgically resected esophageal adenocarcinoma.
Lowenthal BM; Nason KS; Pennathur A; Luketich JD; Pai RK; Davison JM; Ma C
Hum Pathol; 2019 Dec; 94():1-10. PubMed ID: 31655170
[TBL] [Abstract][Full Text] [Related]
31. [Clinical analysis of primary small intestinal neoplasms in 305 cases].
Yang WL; Zhang XC; Yan ZQ; Zhang HM; Zhao Z; Zhang JG; Wang YJ
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):781-3. PubMed ID: 18396694
[TBL] [Abstract][Full Text] [Related]
32. Are there any prognostic factors for small intestinal stromal tumors?
Bucher P; Taylor S; Villiger P; Morel P; Brundler MA
Am J Surg; 2004 Jun; 187(6):761-6. PubMed ID: 15191872
[TBL] [Abstract][Full Text] [Related]
33. Tumor budding assessed according to the criteria of the International Tumor Budding Consensus Conference determines prognosis in resected esophageal adenocarcinoma.
Lohneis P; Hieggelke L; Gebauer F; Ball M; Bruns C; Büttner R; Löser H; Quaas A
Virchows Arch; 2021 Mar; 478(3):393-400. PubMed ID: 32761393
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.
Jun SY; Eom DW; Park H; Bae YK; Jang KT; Yu E; Hong SM
Mod Pathol; 2014 Oct; 27(10):1364-74. PubMed ID: 24603585
[TBL] [Abstract][Full Text] [Related]
35. Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance).
Lee H; Sha D; Foster NR; Shi Q; Alberts SR; Smyrk TC; Sinicrope FA
Ann Oncol; 2020 Apr; 31(4):487-494. PubMed ID: 32165096
[TBL] [Abstract][Full Text] [Related]
36. Tumor budding to investigate local invasion, metastasis and prognosis in temporal bone squamous cell carcinoma.
Alessandrini L; Zanoletti E; Cazzador D; Sbaraglia M; Franz L; Tealdo G; Frigo AC; Blandamura S; Nicolai P; Mazzoni A; Marioni G
Pathol Res Pract; 2022 Jan; 229():153719. PubMed ID: 34953406
[TBL] [Abstract][Full Text] [Related]
37. Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma.
Pan H; Cheng H; Wang H; Ge W; Yuan M; Jiang S; Wan X; Dong Y; Liu Z; Zhao R; Fang Y; Lou F; Cao S; Han W
Cancer Sci; 2021 Nov; 112(11):4758-4771. PubMed ID: 34449929
[TBL] [Abstract][Full Text] [Related]
38. Adenocarcinomas of the jejunum and ileum: a 25-year experience.
Ugurlu MM; Asoglu O; Potter DD; Barnes SA; Harmsen WS; Donohue JH
J Gastrointest Surg; 2005 Nov; 9(8):1182-8. PubMed ID: 16269390
[TBL] [Abstract][Full Text] [Related]
39. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic values of stromal tumor-infiltrating lymphocytes and lymphocyte-activation gene-3 in advanced gastric adenocarcinoma].
Wu ZD; Wang JC; Zhang HJ; Lin JQ; Wu ZZ; Zheng XW; Chen G
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):1007-1012. PubMed ID: 36207914
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
